Early Markers of Cognitive Decline: The Emerging Role of Vascular Dysfunction, Sleep, and Retinal Biomarkers

Recent advancements in neuroscience and clinical research are reshaping our understanding of the earliest indicators of neurodegeneration, particularly Alzheimer’s disease (AD). While traditional focus centered on amyloid plaques and tau tangles, emerging evidence underscores the central role of vascular health and sleep patterns as early, accessible, and actionable biomarkers. These insights open new avenues for early detection, prevention, and intervention, potentially transforming the landscape of dementia care.

---

The Heart–Brain Axis and the Silent Signals of Neurovascular Impairment

The interconnection between cardiovascular health and brain integrity—the heart–brain axis—is increasingly recognized as fundamental in understanding neurodegenerative risk. The Lancet Commission emphasizes that managing vascular risk factors such as hypertension, hypercholesterolemia, and stroke can significantly reduce the incidence of dementia.

Cerebral Small-Vessel Disease (CSVD) and Perfusion Deficits

Cerebral small-vessel disease (CSVD) manifests as subtle changes in the brain's microvasculature and is a predictor of future cognitive decline. Importantly, silent reductions in cerebral blood flow (CBF) often precede the classical pathological markers of AD. Techniques like perfusion MRI and retinal imaging have revealed that decreased brain perfusion can be detected in cognitively normal individuals, serving as early warning signs.

This subclinical hypoperfusion impairs nutrient delivery, hampers the clearance of metabolic waste—including amyloid beta—and activates inflammatory pathways, setting the stage for neurodegeneration years before clinical symptoms appear.

---

Falls and Gait Changes: Accessible Clinical Indicators of Vascular and Neurodegenerative Risk

An increasingly recognized, practical early marker of vascular dysfunction is the occurrence of falls. Epidemiological data show that falls often precede cognitive decline, serving as simple yet powerful clinical indicators.

• Mechanistic link: Vascular impairment leads to brain hypoperfusion, particularly affecting regions responsible for balance and gait.
• Clinical significance: A single fall may correlate with subtle cognitive deficits years prior to formal diagnosis.
• Implication: Routine assessment of fall history could facilitate early screening for neurovascular impairment, prompting further investigations.

---

Sleep Disruption: A Twinned Contributor to Vascular and Neurodegenerative Pathways

Sleep disturbances are both early symptoms and contributors to neurodegeneration. Studies, including recent work from Texas A&M, have demonstrated that poor sleep quality, fragmented sleep, and sleep apnea are linked to accelerated cognitive aging.

Impact on Neurotoxic Waste Clearance and Vascular Health

• Glymphatic system disruption during sleep impairs the clearance of neurotoxic substances such as amyloid beta.
• Sleep disorders increase blood pressure variability and stroke risk, impairing cerebral perfusion.
• Feedback loop: Vascular impairment worsens sleep quality, which in turn exacerbates neurodegenerative processes.

Addressing sleep issues early—via behavioral interventions or treatment of sleep apnea—offers a promising strategy for mitigating neurodegeneration.

---

Innovations in Digital and Imaging Biomarkers: A Multimodal Approach

Advances in technology are facilitating early detection through continuous, non-invasive monitoring:

• Wearable sensors (accelerometers, gyroscopes) can detect gait disturbances and balance issues, providing real-world data on fall risk.
• Passive home monitoring systems enable scalable assessment of mobility and activity patterns.
• Digital cognitive tests, such as spatial navigation assessments, are emerging as early markers of neurodegeneration.
• Retinal imaging—beyond traditional ophthalmology—has gained prominence in detecting early cerebrovascular changes.

The Peripheral Retina as an Early Biomarker

A groundbreaking development is the discovery that peripheral retinal changes may serve as early indicators of Alzheimer’s disease—potentially before significant brain damage occurs. A recent study indicated that retinal microvascular alterations, especially in the peripheral retina, correlate strongly with early AD pathology. This non-invasive approach offers a scalable and accessible window into cerebrovascular health.

Integrating Data for Personalized Risk Stratification

Artificial intelligence (AI) and machine learning are being leveraged to integrate multimodal data streams—from wearable sensors, retinal imaging, sleep assessments, and electronic health records—to generate personalized risk profiles. Such integrated platforms promise scalable screening and targeted interventions.

---

Prevention Strategies and Emerging Therapies

Given the early involvement of vascular and sleep-related markers, prevention efforts should focus on vascular risk management:

• Control of hypertension, cholesterol, and stroke prevention.
• Treatment of sleep disorders, including sleep apnea.
• Lifestyle interventions: physical activity, heart-healthy diets, smoking cessation, and stress reduction.

Emerging pharmacological approaches—such as low-dose lithium—are under investigation for slowing cognitive decline in mild cognitive impairment, aiming to boost neuronal resilience and vascular health.

---

Addressing Disparities and Public Health Considerations

Disparities in dementia incidence are well-documented, with Black and Hispanic populations experiencing higher rates, largely due to social determinants of health and vascular risk factors. Public health initiatives must prioritize community outreach, equitable access to screening, and preventive care to reduce disparities and improve outcomes across populations.

---

Current Status and Future Directions

The convergence of evidence underscores that silent reductions in cerebral blood flow, falls, and sleep disturbances are accessible, early, and actionable biomarkers of neurodegeneration. The recent discovery that peripheral retinal imaging can detect early AD-related vascular changes before brain damage marks a significant milestone.

By integrating vascular risk management, digital health tools, and multimodal biomarkers, there is a promising pathway toward delaying or preventing Alzheimer’s disease. Within the next decade, these strategies could revolutionize dementia prevention, enabling early intervention, preserving brain health, and enhancing quality of life for aging populations worldwide.

---

In summary, recognizing and addressing vascular dysfunction and sleep disturbances early—augmented by innovative imaging and digital technologies—offers a transformative approach to combating neurodegeneration before irreversible brain damage occurs. The future of dementia prevention lies in holistic, personalized, and scalable strategies that integrate physiological signals, clinical markers, and technological advances.